CS204302B1 - Industrial mutant of fungi claviceps purpurea cp 7/63 ccm f-631 - Google Patents
Industrial mutant of fungi claviceps purpurea cp 7/63 ccm f-631 Download PDFInfo
- Publication number
- CS204302B1 CS204302B1 CS160579A CS160579A CS204302B1 CS 204302 B1 CS204302 B1 CS 204302B1 CS 160579 A CS160579 A CS 160579A CS 160579 A CS160579 A CS 160579A CS 204302 B1 CS204302 B1 CS 204302B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- mutant
- ccm
- fungi
- claviceps purpurea
- industrial
- Prior art date
Links
- 241000221751 Claviceps purpurea Species 0.000 title description 2
- DAVNRFCJMIONPO-UHFFFAOYSA-N (7-methyl-6,6a,8,10a-tetrahydro-4h-indolo[4,3-fg]quinoline-9-yl)methanol Chemical class C1=CC(C2C=C(CO)CN(C2C2)C)=C3C2=CNC3=C1 DAVNRFCJMIONPO-UHFFFAOYSA-N 0.000 claims description 9
- XJOOMMHNYOJWCZ-UHFFFAOYSA-N Agroclavine Natural products C1=CC(C2C=C(C)CN(C2C2)C)=C3C2=CNC3=C1 XJOOMMHNYOJWCZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims 1
- 229920001817 Agar Polymers 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 229930013930 alkaloid Natural products 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- ICSSIKVYVJQJND-UHFFFAOYSA-N calcium nitrate tetrahydrate Chemical compound O.O.O.O.[Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ICSSIKVYVJQJND-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
Vynález se týká nové průmyslové mutanty kmene Clavlceps purpurea CP7/63 s vysokou submerzní produkcí farmaceuticky významných alkaloidů agroklavinu (M. Abe et al., Jap. patent 178 336) strukturního vzorce IThe invention relates to a novel industrial mutant of the strain Clavlceps purpurea CP7 / 63 with high submerged production of pharmaceutically important agroclavin alkaloids (M. Abe et al., Japanese Patent 178 336) of structural formula I
(I) a elymoklavinu (M. Abe et al., US Pat. 2 835 675) strukturního vzorce IX(I) and elymoclavin (M. Abe et al., US Pat. 2,835,675) of structural formula IX
Vzorky mutanty jsou uloženy v československé' sbírce mikroorganismů Univerzity J. E. Purkynš v Brně pod δ. CCM F-631.Mutant samples are stored in the Czechoslovak collection of microorganisms at the University of J. E. Purkyns in Brno under δ. CCM F-631
Mutanta byla získána ze 664 izolátú připravených níže popsaným mutačním působením etylmetansulfonátu (EMS) a UV záření na laboratorní kmen Clavioeps purpurea CP7 (Mikrobio204302The mutant was obtained from 664 isolates prepared by the mutation treatment of ethyl methanesulfonate (EMS) and UV radiation on the laboratory strain Clavioeps purpurea CP7 (Microbio204302) as described below.
204302 2 logický ústav ČSAV v Praze 4).' Při přípravě vysokoprodukční mutanty probíhaly veškeré inkubace kultur v temnu při 24 ± 1 °c. Spory mateřské kultury CP7, která byla kultivována 3 až 4 týdny na sešikmená agarová živné půdě T2 (C. Spalla, in Genetics of Industrial Microorganismuá. Eds. Z. Vaněk, Z. Hošlálek, J. Cudlín, Elsevler, Amsterodam 1973, p. 393), byly . suspendovány jednak v 0,066 M fosfátovém pufru pH 7,2, jednak ve fyziologickém roztoku. Výsledná,suspenze obsahovala vždy 1 až 4,10? spor ml“1, z toho pouze 0,5 % až 1 % klíSivých. Agarová živná půda T2 obsahovala tyto složky (g. 1”*’ dest.H2O): sacharóza 100, L-asparagiň 10, Ca(N03)2.4 H2O 1, kvasničný extrakt 0,1, KH2PO4 0,25 MgSC>4.7 H20 0,25, KC1 0,12, FeSO4.7 H2O 0,02, ZnSO4«7 H20 0,015, agar 20, pH 5,2 po sterilizaci v autoklávu při 105 °C 15 min.204302 2 logical institute of the Czechoslovak Academy of Sciences in Prague 4). ' In the preparation of the high production mutant, all incubations of the cultures in the dark were performed at 24 ± 1 ° C. CP7 maternal culture spores that have been cultured for 3 to 4 weeks on sloping T2 agar broth (C. Spalla, in the Genetics of Industrial Microorganisms. Eds. 393) were. suspended in 0.066 M phosphate buffer pH 7.2 and in saline. The resulting suspension always contained 1 to 4.10? spore ml -1, of which only 0.5% to 1% germinable. Agar broth T2 contained the following components (g. 1 * * dest.H 2 O): sucrose 100, L-asparagine 10, Ca (NO 3) 2 .4 H 2 O 1, yeast extract 0.1, KH 2 PO4 0.25 MgSC> 4.7 H 2 0 0.25, KCl 0.12, FeSO 4.7 H 2 O 0.02, ZnSO 4 7 H 2 0 0.015, agar 20, pH 5.2 after autoclaving at 105 ° C 15 min.
Suspenze spor v 0,066 M fosfátovém pufru pH 7,2 byla vystavena 19 hodin, úěinku 0,02 až 0,075 M EMS (J. Nešvera, Fol. Microbiol. 18 /1973/), dvakrát promyta uvedeným pufrem, vyseta na Petriho misky (tf 10 cm) s agarovou půdou T2 obohacenou 0,02 % hydrolyzátu kaseinu (Bactó-Casamino acids Difco) a ihkubována 2 týdny.The spore suspension in 0.066 M phosphate buffer pH 7.2 was exposed for 19 hours, effect 0.02-0.075 M EMS (J. Nesvera, Fol. Microbiol. 18 (1973)), washed twice with said buffer, plated on petri dishes (tf). 10 cm) with T2 agar broth enriched with 0.02% casein hydrolyzate (Bacto-Casamino acids Difco) and incubated for 2 weeks.
Ze suspenze spor ve fyziologickém roztoku bylo přeneseno 5 ml na Petriho misku (d 10 cm) a za stálého pohybu ozařováno zdrojem UV záření nastaveným na 10 J.m“2.s“f dáv- . kami 150 až 1 000 J.m”2. V desetisekundových intervalech bylo odebíráno 0,5 ml sporové suspenze. Po vhodném neředění fyziologickým roztokem byla výsledná suspenze spor přenesena na Petriho misky (/ 10 cm) s agarovou půdou T2 obohacenou 0,02 % hydrolyzátu kaseinu (Bacto-Casamino acids Difco). Takto zaočkovapá živná půda byla inkubována 2 týdny.From the spore suspension in saline, 5 ml was transferred to a Petri dish (d 10 cm) and irradiated with a UV source set to 10 µm "2.s" f dose while moving. 150 to 1,000 µm 2. 0.5 ml of the spore suspension was withdrawn at 10 second intervals. After suitable dilution with saline, the resulting spore suspension was transferred to Petri dishes (/ 10 cm) with T2 agar broth enriched with 0.02% casein hydrolyzate (Bacto-Casamino acids Difco). The inoculated broth was incubated for 2 weeks.
Kolonie vyrostlé z mutagenizovaných spor na agarovém médiu v Petriho miskách byly jednotlivě přeneseny na seáikmenou agarovou půdu T2 a inkubovány 3 až 4 týdny. Narostlé kultury byly pak testovány na schopnost tvořit alkaloidy v podmínkách submerzní fermentace (čs. autorské osvědčení č. 199 986).Colonies grown from mutagenized spores on agar medium in Petri dishes were individually transferred to sown T2 agar broth and incubated for 3-4 weeks. The grown cultures were then tested for their ability to form alkaloids under submerged fermentation conditions (cf. No. 199 986).
Alkaloidy byly stanoveny ve fermentační tekutině 14denníeh kultur kolometricky (G. T. Banks et al., J. Gen. Microbiol. 82, 345 /1974/) a metodou vysokoúčinné kapalinové chromatografie (M. Wurst et al.,. J. Chromát. 150. 477 /1978/).Alkaloids were determined colometrically in fermentation fluid of 14-day cultures (GT Banks et al., J. Gen. Microbiol. 82, 345 (1974)) and by high performance liquid chromatography (M. Wurst et al., J. Chromate. 150. 477). (1978).
Charakteristika vysokoprodukční mutanty:Characteristics of high-production mutant:
Schopnost mutanty tvořit extracelulární směs agroklavinu a elymoklavinu v podmínkách submerzních fermentací je uvedena v tabulce 1.The ability of the mutant to form an extracellular mixture of agroclavin and elymoclavin under submerged fermentation conditions is shown in Table 1.
TabulkalTabulkal
Mutanta CP7/63 je morfologicky shodná s rodičovským kmenem CP7. V podmínkách submerzní fermentace bohatě roste (12 až 20 mg suché váhy mycelia.ml“)), intenzívně eporuluje makroa mikrokonidiemi a produkuje extracelulární glukany-a extracelulární hnědočervený pigment.The CP7 / 63 mutant is morphologically identical to the parental CP7 strain. Under conditions of submerged fermentation it grows abundantly (12 to 20 mg dry weight of mycelia.ml “)), intensively eporulates macro and microconidia and produces extracellular glucans and extracellular brown-red pigment.
Na agarové půdě T2 tvoří nízkou vrstvu šedobílého vzdušného mycelia bohatě větveného spostranními hyfami zakončenými konidiogenními buňkami. U mutanta CP7/63 hmotnostní poměr akroklavin/elymoklavin ve vyprodukované směsi alkaloidů činí 15,6.On the T2 agar medium they form a low layer of off-white airy mycelium richly branched with conspicuous cell-ending hyphae. For the CP7 / 63 mutant, the weight ratio of acroclavin / elymoclavin in the produced alkaloid mixture is 15.6.
Produkční mutanta se uchovává v Endo zkumavkách na agarové půdě T2 a v temnu při téplolě 4 °C. Každá-3 až 4 měsíce se.přeočkovávé a po 30dénní inkubaci při 24 1 1 °C se jich použije k přípravě inokula nebo se uchovává jako zásobní kultura při 4 °C. Mutanta houby Claviceps purpurea označená CP7/63 zabezpečuje klíčový úsek velkokapacitní přípravy alka-·, loidů agroklavinu a elymoklavinu submerzní fermentací.The production mutant is stored in Endo tubes on T2 agar broth and in the dark at 4 ° C. Every 3-4 months they are re-vaccinated and after 30 days incubation at 24 l 1 ° C they are used to prepare the inoculum or stored as a stock culture at 4 ° C. The mutant Claviceps purpurea, designated CP7 / 63, provides a key portion of the large-scale production of alca-, agroclavin, and elymoclavin by submerged fermentation.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS160579A CS204302B1 (en) | 1978-04-19 | 1978-04-19 | Industrial mutant of fungi claviceps purpurea cp 7/63 ccm f-631 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS160579A CS204302B1 (en) | 1978-04-19 | 1978-04-19 | Industrial mutant of fungi claviceps purpurea cp 7/63 ccm f-631 |
Publications (1)
Publication Number | Publication Date |
---|---|
CS204302B1 true CS204302B1 (en) | 1981-04-30 |
Family
ID=5350840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS160579A CS204302B1 (en) | 1978-04-19 | 1978-04-19 | Industrial mutant of fungi claviceps purpurea cp 7/63 ccm f-631 |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS204302B1 (en) |
-
1978
- 1978-04-19 CS CS160579A patent/CS204302B1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4173629A (en) | Antibiotic S 31794/F-1 | |
CN104885931B (en) | A kind of method of ion beam mutation mutagenic and breeding cordyceps militaris link bacterial strain and educated bacterial strain | |
Bennett et al. | Isolation and characterization of two nonaflatoxigenic classes of morphological variants of Aspergillus parasiticus | |
CN101386818A (en) | A kind of extract of marine fungal culture and its preparation method and application | |
Matsumae et al. | Studies on Cerulenin. I Studies on Cerulenin Producing Strain | |
CS204302B1 (en) | Industrial mutant of fungi claviceps purpurea cp 7/63 ccm f-631 | |
WO2006075395A1 (en) | β-LACTAM ANTIBIOTIC ACTIVITY ENHANCER AND PROCESS FOR PRODUCING THE SAME | |
San-Blas et al. | Cell wall analysis of an adenine-requiring mutant of the yeast-like form of Paracoccidioides brasiliensis strain IVIC Pb9 | |
CS204301B1 (en) | Industrial mutant of fungi claviceps purpurea cp 7/5 ccmf-630 with producing alcaloides agroclavine and elymoclavine | |
CN104877914A (en) | High-yield hericium erinaceus induced strain H07 and method for preparing same | |
CS204303B1 (en) | Industrial mutant of fungi claviceps purpurea cp 7/274 ccm f-632 | |
Gaur et al. | Comparative study of a new Chrysosporium species with Histoplasma capsulatum | |
US5457039A (en) | Method for hyper-production of monascus pigments | |
CZ280552B6 (en) | Strain tolypocladium sp.ms 3029, deposited under ccm 8185 for producing cyclosporins in conditions of stationary fermentation | |
CZ208994A3 (en) | Mycelium sterilae ms 2929 strain producing cyclosporins by submerisible fermentation process | |
Volkoff et al. | Virus-like particles in abnormal cells of Saccharomyces carlsbergensis | |
CN107779405A (en) | A kind of coral Paecilomyces varioti strain and its breeding method, application | |
CN110343618A (en) | A kind of helminthosporol type sesquiterpenoids and the preparation method and application thereof | |
CN113604367B (en) | Antrodia camphorate mutant strain E3-64 and application thereof in preparation of triterpenes | |
Shirane et al. | Mineral salt medium for the growth of Botrytis cinerea in vitro | |
CS248612B1 (en) | Industrial mutant of sponge claviceps fusiformis w1 cc-1-85 | |
Jalajakshi | Plant Health Archives | |
US6007812A (en) | Compound MK7634, process for production thereof, and anthelmintic containing said substance | |
CS246704B1 (en) | A productive tribe of microorganisms claviceps purpurea cp-7-5-35-cc-2-85 | |
CS245153B1 (en) | Strain of acremonium chrysogenum microorganism |